ArticleRSC advances2021
Silver nanoparticle on zinc oxide array for label-free detection of opioids through surface-enhanced raman spectroscopy.
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 15 citations in OpenAlex.
- Principles and Applications of ZnO Nanomaterials in Optical Biosensors and ZnO Nanomaterial-Enhanced Biodetection.Biosensors · 2024Review
- Electrochemical sensor based on mesoporous g-CScientific reports · 2024Article
- Silver-Based Surface Plasmon Sensors: Fabrication and Applications.International journal of molecular sciences · 2023Review
- Interpol Review of Drug Analysis 2019-2022.Forensic science international. Synergy · 2023Review
- Plasmonic nanosensors for point-of-care biomarker detection.Materials today. Bio · 2022Review
- Enzyme Sensing Using 2-Mercaptopyridine-Carbonitrile Reporters and Surface-Enhanced Raman Scattering.ACS omega · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
Abstract
Opioid abuse is a significant public health problem. Over two million Americans have some form of addiction to opioids; however, despite governmental programs established to treat overdoses and restrict opioid distribution, there are still few screening tools that are quantitative, portable and easy to use for high-throughput mapping and monitoring this ongoing crisis. In this paper, we demonstrated a plasmonic zinc oxide (ZnO) arrays-on-silicon sensor for the label-free detection of opioids through surface-enhanced Raman spectroscopy (SERS), and evaluated the chips' opioid sensing performance. Specifically, we tested our device with oxycodone, a potent and commonly abused opioid, dissolved in methanol and blood serum as a proof-of-concept study. Ag particles were
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.